The novel lupus antigen related protein acheron enhances the development of human breast cancer

International Journal of Cancer

Volumn 130, Issue 3, 2012, Pages 544-554

  Shao, Rong ^a,b   Scully Jr , Steve J ^a,b   Yan, Wei ^a   Bentley, Brooke ^a   Mueller, James ^c   Brown, Christine ^b   Bigelow, Carol ^b   Schwartz, Lawrence M ^a,b  

^a Pioneer Valley Life Sciences Institute   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c BAYSTATE MEDICAL CENTER   (United States)

Author keywords

invasion; MDA MB 231 cells; metastasis; MMP9; VEGF; xenograft

Indexed keywords

ACHERON; GELATINASE B; GREEN FLUORESCENT PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER SIZE; CELL INVASION; CELL NUCLEUS; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; GENETIC ENGINEERING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LAMELLIPODIA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR VASCULARIZATION; WILD TYPE;

ANIMALS; AUTOANTIGENS; BREAST NEOPLASMS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; INTRACELLULAR SPACE; MICE; MICE, SCID; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; RIBONUCLEOPROTEINS; RNA-BINDING PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 82255175209     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26015     Document Type: Article

References (50)

1. Liotta LA, Steeg PS, Stetler-Stevenson WG,. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 1991; 64: 327-36. (Pubitemid 121001258)
2. Bergers G, Benjamin LE,. Tumorigenesis and the angiogenic switch. Nat Rev Cancer 2003; 3: 401-10. (Pubitemid 37328844)
3. Chambers AF, Groom AC, MacDonald IC,. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-72. (Pubitemid 37328923)
4. Ruoslahti E,. Specialization of tumour vasculature. Nat Rev Cancer 2002; 2: 83-90. (Pubitemid 37328795)
5. Bogenrieder T, Herlyn M,. Axis of evil: Molecular mechanisms of cancer metastasis. Oncogene 2003; 22: 6524-36. (Pubitemid 37372332)
6. Kim D, Kim S, Koh H, Yoon SO, Chung AS, Cho KS, Chung J,. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J 2001; 15: 1953-62. (Pubitemid 32848799)
7. Pulyaeva H, Bueno J, Polette M, Birembaut P, Sato H, Seiki M, Thompson EW,. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis 1997; 15: 111-20. (Pubitemid 27157813)
8. Gilles C, Polette M, Seiki M, Birembaut P, Thompson EW,. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab Invest 1997; 76: 651-60. (Pubitemid 27225095)
9. Kupferman ME, Fini ME, Muller WJ, Weber R, Cheng Y, Muschel RJ,. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol 2000; 157: 1777-83.
10. Rodriguez-Manzaneque JC, Lane TF, Ortega MA, Hynes RO, Lawler J, Iruela-Arispe ML,. Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor. Proc Natl Acad Sci U S A 2001; 98: 12485-90. (Pubitemid 33019972)
11. Yan C, Boyd DD,. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 2007; 211: 19-26. (Pubitemid 46363892)
12. Rundhaug JE,. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005; 9: 267-85.
13. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y,. Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 2006; 231: 20-7. (Pubitemid 43063974)
14. Freudenberg JA, Chen WT,. Induction of Smad1 by MT1-MMP contributes to tumor growth. Int J Cancer 2007; 121: 966-77. (Pubitemid 47101631)
15. Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, Taraboletti G, Giavazzi R,. Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: Implications for ascites formation. Cancer Res 2003; 63: 5224-9. (Pubitemid 37139832)
16. Mira E, Lacalle RA, Buesa JM, de Buitrago GG, Jimenez-Baranda S, Gomez-Mouton C, Martinez-A C, Manes S,. Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface. J Cell Sci 2004; 117: 1847-57.
17. Folkman J, Shing Y,. Angiogenesis. J Biol Chem 1992; 267: 10931-4.
18. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J,. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242-8.
19. Klagsbrun M, D'Amore PA,. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 1996; 7: 259-70. (Pubitemid 27200310)
20. Folkman J, Haudenschild C,. Angiogenesis in vitro. Nature 1980; 288: 551-6. (Pubitemid 11223680)
21. Folkman J,. Tumor angiogenesis. Adv Cancer Res 1985; 43: 175-203.
22. Folkman J,. Tumor angiogenesis: Therapeutic implications. N Engl J Med 1971; 285: 1182-6.
23. Langer R, Conn H, Vacanti J, Haudenschild C, Folkman J,. Control of tumor growth in animals by infusion of an angiogenesis inhibitor. Proc Natl Acad Sci U S A 1980; 77: 4331-5. (Pubitemid 10022605)
24. Valavanis C, Wang Z, Sun D, Vaine M, Schwartz LM,. Acheron, a novel member of the lupus antigen family, is induced during the programmed cell death of skeletal muscles in the moth manduca sexta. Gene 2007; 393: 101-9. (Pubitemid 46551531)
25. Cohen AR, Woods DF, Marfatia SM, Walther Z, Chishti AH, Anderson JM,. Human CASK/LIN-2 binds syndecan-2 and protein 4.1 and localizes to the basolateral membrane of epithelial cells. J Cell Biol 1998; 142: 129-38. (Pubitemid 28341145)
26. Sun R, Su Y, Zhao X, Qi J, Luo X, Yang Z, Yao Y, Luo X, Xia Z,. Human calcium/calmodulin-dependent serine protein kinase regulates the expression of p21 via the E2A transcription factor. Biochem J 2009; 419: 457-66.
27. Cai L, Fritz D, Stefanovic L, Stefanovic B,. Binding of LARP6 to the conserved 5′ stem-loop regulates translation of mRNAs encoding type I collagen. J Mol Biol 2010; 395: 309-26.
28. Cai L, Fritz D, Stefanovic L, Stefanovic B,. Nonmuscle myosin-dependent synthesis of type I collagen. J Mol Biol 2010; 401: 564-78.
29. Wang Z, Glenn H, Brown C, Valavanis C, Liu JX, Seth A, Thomas JE, Karlstrom RO, Schwartz LM,. Regulation of muscle differentiation and survival by acheron. Mech Dev 2009; 126: 700-9.
30. Glenn HL, Wang Z, Schwartz LM,. Acheron, a lupus antigen family member, regulates integrin expression, adhesion, and motility in differentiating myoblasts. Am J Physiol Cell Physiol 2010; 298: C46-55.
31. Cox D, Chang P, Zhang Q, Reddy PG, Bokoch GM, Greenberg S,. Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J Exp Med 1997; 186: 1487-94. (Pubitemid 27479808)
32. Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A, Liao X, Iglehart JD, Livingston DM, Ganesan S,. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006; 9: 121-32. (Pubitemid 43202662)
33. Stasinopoulos I, O'Brien DR, Wildes F, Glunde K, Bhujwalla ZM,. Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells. Mol Cancer Res 2007; 5: 435-42. (Pubitemid 46903952)
34. Miller ME, Holloway AC, Foster WG,. Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output. Clin Exp Metastasis 2005; 22: 149-56. (Pubitemid 41185852)
35. Farina AR, Coppa A, Tiberio A, Tacconelli A, Turco A, Colletta G, Gulino A, Mackay AR,. Transforming growth factor-beta1 enhances the invasiveness of human MDA-MB-231 breast cancer cells by up-regulating urokinase activity. Int J Cancer 1998; 75: 721-30. (Pubitemid 28145819)
36. Larkins TL, Nowell M, Singh S, Sanford GL,. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 2006; 6: 181.
37. Safina A, Vandette E, Bakin AV,. ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells. Oncogene 2007; 26: 2407-22. (Pubitemid 46597273)
38. Shao ZM, Wu J, Shen ZZ, Barsky SH,. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res 1998; 58: 4851-7. (Pubitemid 28503681)
39. Ramos-DeSimone N, Hahn-Dantona E, Sipley J, Nagase H, French DL, Quigley JP,. Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem 1999; 274: 13066-76.
40. Jezierska A, Matysiak W, Motyl T,. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy. Med Sci Monit 2006; 12: BR263-73. (Pubitemid 44186369)
41. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D,. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737-44.
42. Dawood S, Hu R, Homes MD, Collins LC, Schnitt SJ, Connolly J, Colditz GA, Tamimi RM,. Defining breast cancer prognosis based on molecular phenotypes: Results from a large cohort study. Breast Cancer Res Treat 2010;.
43. Gum R, Wang H, Lengyel E, Juarez J, Boyd D,. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 1997; 14: 1481-93. (Pubitemid 27182438)
44. Mehta PB, Jenkins BL, McCarthy L, Thilak L, Robson CN, Neal DE, Leung HY,. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. Oncogene 2003; 22: 1381-9. (Pubitemid 36384600)
45. Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Rao JS,. Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis. Oncogene 2004; 23: 4681-9. (Pubitemid 38859457)
46. Cheung LW, Leung PC, Wong AS,. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9. Cancer Res 2006; 66: 10902-10. (Pubitemid 44876988)
47. Wang J, Ou ZL, Hou YF, Luo JM, Shen ZZ, Ding J, Shao ZM,. Enhanced expression of duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential. Oncogene 2006; 25: 7201-11. (Pubitemid 44764189)
48. Biesiada E, Razandi M, Levin ER,. Egr-1 activates basic fibroblast growth factor transcription. mechanistic implications for astrocyte proliferation. J Biol Chem 1996; 271: 18576-81. (Pubitemid 26322719)
49. Woo JH, Park JW, Lee SH, Kim YH, Lee IK, Gabrielson E, Lee SH, Lee HJ, Kho YH, Kwon TK,. Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activity. Cancer Res 2003; 63: 3430-4. (Pubitemid 36735905)
50. Troussard AA, Costello P, Yoganathan TN, Kumagai S, Roskelley CD, Dedhar S,. The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene 2000; 19: 5444-52. (Pubitemid 32000911)